Retail sales of prescription drug products in the world's 10 leading markets totaled $11.68 billion in January 1996, a rise of 9% on January 1995's result, reports IMS International. This good growth came despite a 7% decline in sales in Japan (excluding the hospital sector), which were down $1.65 billion during the month.
Most other leading markets reported good growth, with US sales advancing 14% to $4.72 billion. The biggest increases were reported for Italy and Belgium, both up 17% to $739 million and $177 million respectively, while Germany and the UK both grew 14% to $1.51 billion and $546 million respectively. Sales in Spain were up 12% to $451 million, while turnover in the Netherlands advanced 9% to $178 million and the French market increased 6% to $1.38 billion.
The only market decline other than Japan was reported for Canada, which dropped 7% to $309 million to give a total January sales increase for the North American market of 12% at $5.03 billion.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze